108 related articles for article (PubMed ID: 27498210)
21. Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.
Will BP; Le Petit C; Berthelot JM; Tomiak EM; Verma S; Evans WK
Br J Cancer; 1999 Mar; 79(9-10):1428-36. PubMed ID: 10188886
[TBL] [Abstract][Full Text] [Related]
22. Outpatient treatment costs and their potential impact on cancer care.
Isshiki T
Cancer Med; 2014 Dec; 3(6):1539-43. PubMed ID: 25060622
[TBL] [Abstract][Full Text] [Related]
23. The cost and burden of cancer in the European Union 1995-2014.
Jönsson B; Hofmarcher T; Lindgren P; Wilking N
Eur J Cancer; 2016 Oct; 66():162-70. PubMed ID: 27589247
[TBL] [Abstract][Full Text] [Related]
24. Costs of hospitalization with respiratory syncytial virus illness among children aged <5 years and the financial impact on households in Bangladesh, 2010.
Bhuiyan MU; Luby SP; Alamgir NI; Homaira N; Sturm-Ramirez K; Gurley ES; Abedin J; Zaman RU; Alamgir A; Rahman M; Ortega-Sanchez IR; Azziz-Baumgartner E
J Glob Health; 2017 Jun; 7(1):010412. PubMed ID: 28702175
[TBL] [Abstract][Full Text] [Related]
25. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
Rothbard AB; Lee S; Blank MB
J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
[TBL] [Abstract][Full Text] [Related]
26. Estimated annual health care expenditures in individuals with peripheral arterial disease.
Scully RE; Arnaoutakis DJ; DeBord Smith A; Semel M; Nguyen LL
J Vasc Surg; 2018 Feb; 67(2):558-567. PubMed ID: 28847660
[TBL] [Abstract][Full Text] [Related]
27. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
Sagar B; Lin YS; Castel LD
J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
[TBL] [Abstract][Full Text] [Related]
28. Physical activity and health services utilization and costs among U.S. adults.
Kang SW; Xiang X
Prev Med; 2017 Mar; 96():101-105. PubMed ID: 28040516
[TBL] [Abstract][Full Text] [Related]
29. Adverse breast cancer treatment effects: the economic case for making rehabilitative programs standard of care.
Schmitz KH; DiSipio T; Gordon LG; Hayes SC
Support Care Cancer; 2015 Jun; 23(6):1807-17. PubMed ID: 25471182
[TBL] [Abstract][Full Text] [Related]
30. Direct costs of interferon-based and interferon-free direct-acting antiviral regimens for the treatment of chronic hepatitis C infection.
Gray E; O'Leary A; Kieran JA; Fogarty E; Dowling T; Norris S;
J Viral Hepat; 2016 Sep; 23(9):677-86. PubMed ID: 26996144
[TBL] [Abstract][Full Text] [Related]
31. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
32. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
[TBL] [Abstract][Full Text] [Related]
33. [Standard treatment cost of female breast cancer at different TNM stages].
Li H; Huang Y; Huang R; Li JY
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):946-50. PubMed ID: 24506967
[TBL] [Abstract][Full Text] [Related]
34. Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program.
Frey P; Stinson T; Siston A; Knight SJ; Ferdman E; Traynor A; O'Gara K; Rademaker A; Bennett C; Winter JN
Bone Marrow Transplant; 2002 Dec; 30(11):741-8. PubMed ID: 12439696
[TBL] [Abstract][Full Text] [Related]
35. 'More than just money' -- widening the understanding of the costs involved in cancer care.
Pearce S; Kelly D; Stevens W
J Adv Nurs; 2001 Feb; 33(3):371-9. PubMed ID: 11251724
[TBL] [Abstract][Full Text] [Related]
36. Patterns of treatment, healthcare utilization and costs by lines of therapy in metastatic breast cancer in a large insured US population.
Ray S; Bonthapally V; McMorrow D; Bonafede M; Landsman-Blumberg P
J Comp Eff Res; 2013 Mar; 2(2):195-206. PubMed ID: 24236561
[TBL] [Abstract][Full Text] [Related]
37. Medical Care Costs of Breast Cancer in Privately Insured Women Aged 18-44 Years.
Allaire BT; Ekwueme DU; Guy GP; Li C; Tangka FK; Trivers KF; Sabatino SA; Rodriguez JL; Trogdon JG
Am J Prev Med; 2016 Feb; 50(2):270-7. PubMed ID: 26775906
[TBL] [Abstract][Full Text] [Related]
38. Incremental direct medical costs of systemic lupus erythematosus patients in the years preceding diagnosis: A general population-based study.
McCormick N; Marra CA; Sadatsafavi M; Aviña-Zubieta JA
Lupus; 2018 Jul; 27(8):1247-1258. PubMed ID: 29665755
[TBL] [Abstract][Full Text] [Related]
39. The impact of obesity on health service utilization and costs in childhood.
Trasande L; Chatterjee S
Obesity (Silver Spring); 2009 Sep; 17(9):1749-54. PubMed ID: 19300433
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
Jahnz-Rózyk K; Targowski T; From S
Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
